| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | TEVA PHARMACEUTICAL INDS LTD | 4,724,450 | 171,261,000 | 8.92% | ||
| 2 | MYLAN N V | 4,145,889 | 158,166,000 | 8.24% | ||
| 3 | STRYKER CORP | 1,000,000 | 119,810,000 | 6.24% | Put | |
| 4 | ALLERGAN PLC | 543,000 | 114,035,000 | 5.94% | ||
| 5 | GILEAD SCIENCES INC | 1,500,000 | 107,415,000 | 5.59% | ||
| 6 | PERRIGO CO PLC | 1,208,200 | 100,558,000 | 5.24% | ||
| 7 | SELECT MED HLDGS CORP COM | 6,025,000 | 79,831,000 | 4.16% | ||
| 8 | NEKTAR THERAPEUTICS COM | 6,000,000 | 73,620,000 | 3.83% | ||
| 9 | GENOMIC HEALTH INC COM | 2,458,100 | 72,244,000 | 3.76% | ||
| 10 | GILEAD SCIENCES INC | 1,000,000 | 71,610,000 | 3.73% | Call | |
| 11 | BROOKDALE SR LIVING INC | 5,500,000 | 68,310,000 | 3.56% | ||
| 12 | MYRIAD GENETICS INC | 4,060,000 | 67,680,000 | 3.52% | ||
| 13 | ENDO INTL | 3,902,000 | 64,266,000 | 3.35% | ||
| 14 | CARDIOVASCULAR SYS INC DEL COM | 2,500,000 | 60,525,000 | 3.15% | ||
| 15 | ALKERMES PLC SHS | 1,000,000 | 55,580,000 | 2.89% | ||
| 16 | VERTEX PHARMACEUT | 750,000 | 55,253,000 | 2.88% | ||
| 17 | ORTHOFIX INTERNATIONAL NV | 1,500,000 | 54,270,000 | 2.83% | ||
| 18 | LIVANOVA PLC | 1,200,000 | 53,964,000 | 2.81% | ||
| 19 | BIOGEN INC | 175,000 | 49,626,000 | 2.58% | ||
| 20 | UNIVERSAL AMERN CORP NEW | 4,875,000 | 48,506,000 | 2.53% | ||
| 21 | AMGEN INC | 300,000 | 43,863,000 | 2.28% | ||
| 22 | ABBOTT LABS | 1,000,000 | 38,410,000 | 2.00% | ||
| 23 | CONMED CORP | 750,000 | 33,128,000 | 1.73% | ||
| 24 | ATHENA HEALTH INC. | 300,000 | 31,551,000 | 1.64% | ||
| 25 | AMAG PHARMACEUTICALS INC COM | 611,390 | 21,276,000 | 1.11% | ||
| 26 | ENDOLOGIX INC | 3,635,000 | 20,792,000 | 1.08% | ||
| 27 | SYNERON MEDICAL LTD ORD SHS | 2,347,593 | 19,720,000 | 1.03% | ||
| 28 | INVITAE CORP | 2,398,123 | 19,041,000 | 0.99% | ||
| 29 | CENTENE CORP DEL | 200,000 | 11,302,000 | 0.59% | ||
| 30 | BIOSCRIP INC | 10,180,000 | 10,587,000 | 0.55% | ||
| 31 | BIOLASE INC | 5,332,394 | 7,465,000 | 0.39% | ||
| 32 | ARENA PHARMACEUTICALS INC | 4,250,000 | 6,035,000 | 0.31% | ||
| 33 | PROTALIX BIOTHERAPEUTICS INC | 9,000,000 | 4,579,000 | 0.24% | PRN | |
| 34 | Catabasis Pharmaceuticals Inc | 1,000,000 | 3,610,000 | 0.19% | ||
| 35 | TARGACEPT INC | 1,684,799 | 1,685,000 | 0.09% | PRN | |
| 36 | DEXTERA SURGICAL | 837,483 | 804,000 | 0.04% | ||
| 37 | BIOLASE INC | 1,841,173 | 0 | 0.00% | Call |
Portfolio data is normalized using SEC Form 13F filings, including the Restatement filing (0001654954-17-002061, filed 2017.03.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
